[1]
C. Alcarraz, “Optimal cytoreduction in advanced ovarian cancer treated with dose-dense paclitaxel and carboplatin followed by interval surgery at the peruvian national institute of neoplastic diseases”, Rev Peru Med Exp Salud Publica, vol. 35, no. 1, pp. 46–54, Apr. 2018, doi: 10.17843/rpmesp.2018.351.3599.